Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of Micropulse Laser Trabeculoplasty Versus Selective Laser Trabeculoplasty for Treatment of Open Angle Glaucoma

NCT01956942 is registered in ClinicalTrials.gov with David Belyea as lead sponsor.

NCT NCT01956942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01956942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of Micropulse Laser Trabeculoplasty Versus Selective Laser Trabeculoplasty for Treatment of Open Angle Glaucoma
Lead sponsor
David Belyea
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2013
Completion date
July 24, 2017
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

open angle glaucoma